Skip to main content
Erschienen in: Medical Oncology 3/2010

01.09.2010 | Original Paper

Primary gastrointestinal non-Hodgkin’s lymphoma: clinicopathological and prognostic analysis

verfasst von: Tong Wang, Wei Gui, Quanliang Shen

Erschienen in: Medical Oncology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

The objective is to investigate the association between pathological type and clinical features, response to treatment and prognosis of primary gastrointestinal Non-Hodgkin’s lymphoma (PGINHL). The clinicopathologic features, response to treatment and survival of 124 patients with PGINHL, were investigated retrospectively. Ninety-one patients were treated with surgery, most of which included combined therapy, while 32 patients received chemotherapy alone. Survival analysis was performed by Kaplan–Meier and Cox regression method. The most common immunophenotype was B-cell subtype. In 115 (92.7%) patients of B-cell lymphoma, mucosa-associated lymphoid tissue lymphoma (MALToma) and diffuse large B-cell lymphoma (DLBCL) were 55 and 50 patients, respectively. The patients of two pathological types had different clinical features including stage, B symptoms, sites of tumor, distant involvement, International Prognosis Index Score, size of tumor, and response to treatment. Both overall survival curve and multiple Cox regression analysis indicated that pathological type was statistically significant. The pathological subtype of PGINHL was an important prognostic factor. The patients with MALToma appear to have more favorable prognosis than those with DLBCL.
Literatur
1.
Zurück zum Zitat Binn M, Ruskone-Fourmestraux A, Lepage E, et al. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol. 2003;14:1751–7.CrossRefPubMed Binn M, Ruskone-Fourmestraux A, Lepage E, et al. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol. 2003;14:1751–7.CrossRefPubMed
2.
Zurück zum Zitat Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German multicenter study GIT NHL 01/92. J Clin Oncol. 2001;19:3861–73.PubMed Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German multicenter study GIT NHL 01/92. J Clin Oncol. 2001;19:3861–73.PubMed
3.
Zurück zum Zitat Nakamura S, Matsumoto T, Lida M, et al. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97:2462–72.CrossRefPubMed Nakamura S, Matsumoto T, Lida M, et al. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97:2462–72.CrossRefPubMed
4.
Zurück zum Zitat Gurney KA, Cartwright RA, Gilman EA. Descriptive epidemiology of gastrointestinal non-Hodgkin’s lymphoma in a population-based registry. Br J Cancer. 1999;79:1929–34.CrossRefPubMed Gurney KA, Cartwright RA, Gilman EA. Descriptive epidemiology of gastrointestinal non-Hodgkin’s lymphoma in a population-based registry. Br J Cancer. 1999;79:1929–34.CrossRefPubMed
5.
Zurück zum Zitat Nakamura S, Matsumoto T, Takeshita M, et al. A clinicopathologic study of primary small intestine lymphoma. Cancer. 2000;88:286–94.CrossRefPubMed Nakamura S, Matsumoto T, Takeshita M, et al. A clinicopathologic study of primary small intestine lymphoma. Cancer. 2000;88:286–94.CrossRefPubMed
6.
Zurück zum Zitat Lin XG, Huang KH, Xie DR, et al. Pognostic factor analysis of 116 cases of primary gastrointestinal non-Hodgkin’s lymphoma. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28(2):243–5.PubMed Lin XG, Huang KH, Xie DR, et al. Pognostic factor analysis of 116 cases of primary gastrointestinal non-Hodgkin’s lymphoma. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28(2):243–5.PubMed
7.
Zurück zum Zitat Isaacson PG, Du MQ. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol. 2005;205:255–74.CrossRefPubMed Isaacson PG, Du MQ. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol. 2005;205:255–74.CrossRefPubMed
8.
Zurück zum Zitat Sugimoto M, Kajimura M, Shirai N, et al. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobactor pylori eradication therapy. Intern Med. 2006;45:405–9.CrossRefPubMed Sugimoto M, Kajimura M, Shirai N, et al. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobactor pylori eradication therapy. Intern Med. 2006;45:405–9.CrossRefPubMed
9.
Zurück zum Zitat Schechter NR, Yahalom J. Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiat Oncol Biol Phys. 2000;46:1093–103.PubMed Schechter NR, Yahalom J. Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiat Oncol Biol Phys. 2000;46:1093–103.PubMed
10.
Zurück zum Zitat Aviles A, Nambo MJ, Neri N, et al. Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial. Med Oncol. 2005;22:57–62.CrossRefPubMed Aviles A, Nambo MJ, Neri N, et al. Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial. Med Oncol. 2005;22:57–62.CrossRefPubMed
11.
Zurück zum Zitat Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008;19(12):1992–9.CrossRefPubMed Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008;19(12):1992–9.CrossRefPubMed
12.
Zurück zum Zitat Yoshida N, Wakabayashi N, Nomura K, et al. Ileal mucosa-associated lymphoid tissue lymphoma showing several ulcer scars detected using double-balloon endoscopy. Endoscopy. 2004;36:1022–4.CrossRefPubMed Yoshida N, Wakabayashi N, Nomura K, et al. Ileal mucosa-associated lymphoid tissue lymphoma showing several ulcer scars detected using double-balloon endoscopy. Endoscopy. 2004;36:1022–4.CrossRefPubMed
13.
Zurück zum Zitat Koch P, del Valle F, Berdes WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: II. Combined surgical and conservative or conservation management only in localized gastric lymphoma-results of the prospective German Multicenter study GIT NHL.01/92. J Clin Oncol. 2001;19:2874–83. Koch P, del Valle F, Berdes WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: II. Combined surgical and conservative or conservation management only in localized gastric lymphoma-results of the prospective German Multicenter study GIT NHL.01/92. J Clin Oncol. 2001;19:2874–83.
14.
Zurück zum Zitat Chim CS, Loong F, Ooi GC. Mucosa-associated lymphoid tissue (MALT) lymphoma of the jejunum: an elusive cause of recurrent upper gastrointestinal bleeding. Leuk Lymphoma. 2004;45:405–7.CrossRefPubMed Chim CS, Loong F, Ooi GC. Mucosa-associated lymphoid tissue (MALT) lymphoma of the jejunum: an elusive cause of recurrent upper gastrointestinal bleeding. Leuk Lymphoma. 2004;45:405–7.CrossRefPubMed
15.
Zurück zum Zitat Hjermstad MJ, Hollender A, Warloe T, et al. Quality of life after total or partial gastrectomy for primary gastric lymphoma. Acta Oncol. 2006;45:202–9.CrossRefPubMed Hjermstad MJ, Hollender A, Warloe T, et al. Quality of life after total or partial gastrectomy for primary gastric lymphoma. Acta Oncol. 2006;45:202–9.CrossRefPubMed
16.
Zurück zum Zitat Aviles A, Nambo MJ, Neri N, et al. The role of surgery in primary gastric lymphoma results of a controlled clinical trial. Ann Surg. 2004;240:44–50.CrossRefPubMed Aviles A, Nambo MJ, Neri N, et al. The role of surgery in primary gastric lymphoma results of a controlled clinical trial. Ann Surg. 2004;240:44–50.CrossRefPubMed
17.
Zurück zum Zitat Ishikura S, Tobinai K, Ohtsu A, et al. Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II1, diffuse large B-cell lymphoma of the stomach. Cancer Sci. 2005;96:349–52.CrossRefPubMed Ishikura S, Tobinai K, Ohtsu A, et al. Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II1, diffuse large B-cell lymphoma of the stomach. Cancer Sci. 2005;96:349–52.CrossRefPubMed
18.
Zurück zum Zitat Park YH, Lee SH, Kim WS, et al. CHOP followed by involved field radiotherapy for localized primary gastric diffuse large B-cell lymphoma: results of a multicenter phase II study and quality of life evaluation. Leuk Lymphoma. 2006;47:1253–9.CrossRefPubMed Park YH, Lee SH, Kim WS, et al. CHOP followed by involved field radiotherapy for localized primary gastric diffuse large B-cell lymphoma: results of a multicenter phase II study and quality of life evaluation. Leuk Lymphoma. 2006;47:1253–9.CrossRefPubMed
19.
Zurück zum Zitat Lee J, Kim WS, Kim K, et al. Intestinal lymphoma: exploration of the prognostic factors and optimal treatment. Leuk Lymphoma. 2004;45:339–44.CrossRefPubMed Lee J, Kim WS, Kim K, et al. Intestinal lymphoma: exploration of the prognostic factors and optimal treatment. Leuk Lymphoma. 2004;45:339–44.CrossRefPubMed
20.
Zurück zum Zitat Ibrahim EM, Ezz AA, Etweshi AN, et al. Primary intestinal diffuse large B-cell non-Hodgkin’s lymphoma: clinical features, management, and prognosis of 66 patients. Ann Oncol. 2001;12:53–8.CrossRefPubMed Ibrahim EM, Ezz AA, Etweshi AN, et al. Primary intestinal diffuse large B-cell non-Hodgkin’s lymphoma: clinical features, management, and prognosis of 66 patients. Ann Oncol. 2001;12:53–8.CrossRefPubMed
21.
Zurück zum Zitat Gonzalez QH, Heslin MJ, Davila-cervants A, et al. Primary colonic lymphoma. Am Surg. 2008;74(3):214–6.PubMed Gonzalez QH, Heslin MJ, Davila-cervants A, et al. Primary colonic lymphoma. Am Surg. 2008;74(3):214–6.PubMed
Metadaten
Titel
Primary gastrointestinal non-Hodgkin’s lymphoma: clinicopathological and prognostic analysis
verfasst von
Tong Wang
Wei Gui
Quanliang Shen
Publikationsdatum
01.09.2010
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 3/2010
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-009-9265-1

Weitere Artikel der Ausgabe 3/2010

Medical Oncology 3/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.